Impaired p53 function leads to centrosome amplification, acquired ERα phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts-Reference-Cited by-同舟云学术

Impaired p53 function leads to centrosome amplification, acquired ERα phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts

Published:2008-02-11 Issue:28 Volume:27 Page:3901-3911
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

D'Assoro A B,Busby R,Acu I D,Quatraro C,Reinholz M M,Farrugia D J,Schroeder M A,Allen C,Stivala F,Galanis E,Salisbury J L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc200818.pdf

Reference49 articles.

1. Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N et al. (2004). Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 64: 3198–3208.

2. Angeloni SV, Martin MB, Garcia-Morales P, Castro-Galache MD, Ferragut JA, Saceda M . (2004). Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J Endocrinol 180: 497–504.

3. Bennett RA, Izumi H, Fukasawa K . (2004). Induction of centrosome amplification and chromosome instability in p53-null cells by transient exposure to subtoxic levels of S-phase-targeting anticancer drugs. Oncogene 23: 6823–6829.

4. Bindels EM, Lallemand F, Balkenende A, Verwoerd D, Michalides R . (2002). Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Oncogene 21: 8158–8165.

5. Brinkley BR, Goepfert TM . (1998). Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. Cell Motil Cytoskeleton 41: 281–288.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Centrosome Pathologies on Ovarian Cancer Development and Progression with a Focus on Centrosomes as Therapeutic Target;Advances in Experimental Medicine and Biology;2024

2. Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt;Oncology Reports;2021-12-24

3. Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story;Current Chemical Biology;2021-08-09

4. Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies;Cancer and Metastasis Reviews;2020-10-26

5. Development of a potent peptide inhibitor of estrogen receptor α;Chinese Chemical Letters;2018-07